Colgate-Palmolive Company $CL Shares Acquired by Cerity Partners LLC

Cerity Partners LLC boosted its holdings in Colgate-Palmolive Company (NYSE:CLFree Report) by 8.6% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 651,402 shares of the company’s stock after acquiring an additional 51,620 shares during the period. Cerity Partners LLC owned 0.08% of Colgate-Palmolive worth $59,212,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Grimes & Company Inc. grew its holdings in shares of Colgate-Palmolive by 1.0% during the 2nd quarter. Grimes & Company Inc. now owns 12,495 shares of the company’s stock worth $1,136,000 after purchasing an additional 118 shares during the period. RFG Advisory LLC lifted its position in Colgate-Palmolive by 1.4% in the second quarter. RFG Advisory LLC now owns 9,227 shares of the company’s stock valued at $839,000 after buying an additional 123 shares during the last quarter. Tiemann Investment Advisors LLC boosted its stake in Colgate-Palmolive by 2.1% during the second quarter. Tiemann Investment Advisors LLC now owns 6,083 shares of the company’s stock worth $553,000 after buying an additional 125 shares during the period. Redhawk Wealth Advisors Inc. increased its position in shares of Colgate-Palmolive by 2.4% during the second quarter. Redhawk Wealth Advisors Inc. now owns 5,467 shares of the company’s stock valued at $497,000 after acquiring an additional 129 shares during the last quarter. Finally, Westside Investment Management Inc. raised its stake in shares of Colgate-Palmolive by 85.5% in the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after acquiring an additional 130 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. Citigroup lowered their price objective on shares of Colgate-Palmolive from $105.00 to $95.00 and set a “buy” rating for the company in a research report on Monday, November 3rd. The Goldman Sachs Group dropped their price objective on Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating for the company in a research note on Thursday, October 2nd. Bank of America cut their price objective on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating on the stock in a report on Wednesday, October 8th. Weiss Ratings restated a “hold (c)” rating on shares of Colgate-Palmolive in a report on Wednesday, October 8th. Finally, Wells Fargo & Company cut their price target on shares of Colgate-Palmolive from $80.00 to $77.00 and set an “underweight” rating on the stock in a research note on Monday, November 3rd. Nine investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $89.87.

Get Our Latest Report on Colgate-Palmolive

Colgate-Palmolive Trading Up 0.6%

CL opened at $78.04 on Monday. The business has a fifty day moving average price of $78.42 and a 200 day moving average price of $83.99. The company has a debt-to-equity ratio of 5.90, a current ratio of 0.93 and a quick ratio of 0.60. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $100.18. The stock has a market capitalization of $62.91 billion, a price-to-earnings ratio of 21.86, a PEG ratio of 5.56 and a beta of 0.30.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its quarterly earnings data on Friday, October 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.02. Colgate-Palmolive had a return on equity of 333.39% and a net margin of 14.47%.The business had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.17 billion. During the same quarter last year, the business posted $0.91 EPS. The business’s quarterly revenue was up 1.9% compared to the same quarter last year. Sell-side analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, November 14th. Shareholders of record on Friday, October 17th were issued a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 2.7%. The ex-dividend date was Friday, October 17th. Colgate-Palmolive’s payout ratio is 58.26%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.